These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17595179)

  • 21. Strategies to reverse endothelial dysfunction in diabetic nephropathy.
    Badal SS; Danesh FR
    Kidney Int; 2012 Dec; 82(11):1151-4. PubMed ID: 23151985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease.
    Binion DG; Rafiee P
    Gastroenterology; 2009 Feb; 136(2):400-3. PubMed ID: 19111728
    [No Abstract]   [Full Text] [Related]  

  • 23. [Endothelial dysfunction and diabetes: possible role in kidney damage].
    Tesauro M; Leo R; Lauro R; Cardillo C
    G Ital Nefrol; 2009; 26 Suppl 46():62-70. PubMed ID: 19644821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
    Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P
    Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.
    Nishimura M; Izumiya Y; Higuchi A; Shibata R; Qiu J; Kudo C; Shin HK; Moskowitz MA; Ouchi N
    Circulation; 2008 Jan; 117(2):216-23. PubMed ID: 18158361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down regulation of aortic nitric oxide and antioxidant systems in chronic alcohol-induced hypertension in rats.
    Husain K; Vazquez-Ortiz M; Lalla J
    Hum Exp Toxicol; 2007 May; 26(5):427-34. PubMed ID: 17623767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
    Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
    Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].
    Pokrovskiĭ MV; Pokrovskaia TG; Kochkarov VI; Artiushkova EB
    Eksp Klin Farmakol; 2008; 71(2):29-31. PubMed ID: 18488903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism.
    Nakagawa T
    Clin Nephrol; 2009 Feb; 71(2):103-9. PubMed ID: 19203501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species.
    Schwedler SB; Kuhlencordt PJ; Ponnuswamy PP; Hatiboglu G; Quaschning T; Widder J; Wanner C; Potempa LA; Galle J
    Atherosclerosis; 2007 Dec; 195(2):e76-84. PubMed ID: 17669410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function.
    Matsui A; Okigaki M; Amano K; Adachi Y; Jin D; Takai S; Yamashita T; Kawashima S; Kurihara T; Miyazaki M; Tateishi K; Matsunaga S; Katsume A; Honshou S; Takahashi T; Matoba S; Kusaba T; Tatsumi T; Matsubara H
    Circulation; 2007 Aug; 116(9):1041-51. PubMed ID: 17698736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus.
    Sasaki N; Yamashita T; Takaya T; Shinohara M; Shiraki R; Takeda M; Emoto N; Fukatsu A; Hayashi T; Ikemoto K; Nomura T; Yokoyama M; Hirata K; Kawashima S
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1068-76. PubMed ID: 18403727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanisms of diabetic nephropathy--endothelial dysfunction].
    Yozai K; Shikata K; Makino H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():341-5. PubMed ID: 15999731
    [No Abstract]   [Full Text] [Related]  

  • 34. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging role of VEGF in diabetic kidney disease.
    Khamaisi M; Schrijvers BF; De Vriese AS; Raz I; Flyvbjerg A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1427-30. PubMed ID: 12897074
    [No Abstract]   [Full Text] [Related]  

  • 36. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
    Levine DZ
    Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do adenosine receptors offer new therapeutic options for diabetic nephropathy?
    San Martín R; Valladares D; Roa H; Troncoso E; Sobrevia L
    Curr Vasc Pharmacol; 2009 Oct; 7(4):450-9. PubMed ID: 19485887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating SIRT1: a new strategy to prevent atherosclerosis?
    Brandes RP
    Cardiovasc Res; 2008 Nov; 80(2):163-4. PubMed ID: 18784217
    [No Abstract]   [Full Text] [Related]  

  • 39. Glomerular endothelial dysfunction in type 2 diabetes mellitus.
    Futrakul N; Butthep P; Futrakul P; Sittipreja V
    Ren Fail; 2006; 28(6):523-4. PubMed ID: 16928624
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal endothelial dysfunction in diabetic nephropathy.
    Cheng H; Harris RC
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):22-33. PubMed ID: 24720460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.